April 09, 2009 -- MonoSol Rx, the developers of PharmFilm technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. , today announced the submission on April 7, 2009 of a New Drug Application to the U.S. FDA for the orally dissolving film strip (ODFS) formulation of ondansetron.
The details can be read here.
No comments:
Post a Comment